MENU
CTXR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Citius Pharmaceuticals (CTXR) Earnings Date & Reports

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy... Show more

A.I. Advisor
published Earnings

CTXR is expected to report earnings to fall 96.06% to -5 cents per share on November 27

Citius Pharmaceuticals CTXR Stock Earnings Reports
Q3'24
Est.
$-0.05
Q1'25
Missed
by $1.31
Q2'24
Missed
by $0.01
Q1'24
Est.
$-0.05
Q4'23
Missed
by $0.19
The last earnings report on May 14 showed earnings per share of -126 cents, missing the estimate of 3 cents. With 106.41K shares outstanding, the current market capitalization sits at 8.54M.
View a ticker or compare two or three
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
22
Web
https://www.citiuspharma.com